ALSO NOTED: Merck vaccine prevents cervical cancer in older women; Diabetes sales drive 37 percent increase in Takeda profits;

> Gardasil protects against cervical cancer in women as old as 45, a new study shows; previously, the vaccine was only proven to work in women ages 9 to 26. Report

> Strong sales of its Actos diabetes drug boosted Takeda Pharmaceuticals to a 37 percent hike in half-year profits. Report

> Cardinal Health posted an 11 percent increase in profits to $301.8 million, but trouble in its pharmaceutical supply-chain services unit prompted a change in management. Report

> Prague's Zentiva Pharmaceuticals saw profits fall 31 percent in the first nine months, but it expects full-year sales to come in with 20 percent growth. Report

> The FDA warned consumers against two unapproved products sold as ED treatments; they contain potentially harmful ingredients that can cause low blood pressure, the agency said. Report

And Finally... Besides its obvious effects, the ED remedy sildenafil citrate may also be a love potion. Report

Suggested Articles

Mylan and Pfizer's Upjohn have a name for their pending merger: Viatris. Heard that before? So has Mylan, which owns a subsidiary with the same name.

Intercept presented a data analysis that found treatment with Ocaliva led to "early and consistent improvements" in a range of noninvasive tests.

Days before Amarin faces a pivotal FDA vote on its Vascepa expansion, advisors are set to scrutinize the placebo used in its pivotal outcomes trial.